Skip to content

A randomised controlled trial comparing Phospo-Soda Buffered Saline (Fleet ®) with Sodium Picosulphate/Magnesium Citrate (Picoprep ®) in the preparation of patients for colonoscopy".

A Randomised Controlled Trial (RCT) comparing the efficacy and acceptability of Phospo-Soda Buffered Saline (Fleet ®) with Sodium Picosulphate/Magnesium Citrate (Picoprep ®) in the preparation of patients for colonoscopy.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12607000337471
Acronym
Fleet V Picoprep
Enrollment
73
Registered
2007-06-25
Start date
2004-01-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The adequacy and efficacy of various small-volume bowel preparations for colonoscopy has become increasingly popular due to improved tolerance by patients and equivalent efficacy compared with the larger volume preparations. Comparative studies however between small volume preparations are lacking. This randomised controlled trial aims to compare the efficacy and acceptability of phospo-soda buffered saline (Fleet ®) with sodium picosulphate/ magnesium citrate (Picoprep ®) in the preparation of patients for colonoscopy.

Interventions

A randomised prospective trial designed to compare the efficacy and acceptability of phospo-soda buffered saline (Fleet ®)(control) with sodium picosulphate/ magnesium citrate (Picoprep ®) (intervention) in patients undergoing colonoscopy.The prepartion All patients also received 3 Bisacodyl tablets (Dulcolax, Boehringer Ingelheim, Germany) 2 days before the procedure (one day before phospo-soda buffered saline (Fleet) or sodium picosulphate/ magnesium citrate (picoprep)). Patients were encoura

A randomised prospective trial designed to compare the efficacy and acceptability of phospo-soda buffered saline (Fleet ®)(control) with sodium picosulphate/ magnesium citrate (Picoprep ®) (intervention) in patients undergoing colonoscopy.The prepartion All patients also received 3 Bisacodyl tablets (Dulcolax, Boehringer Ingelheim, Germany) 2 days before the procedure (one day before phospo-soda buffered saline (Fleet) or sodium picosulphate/ magnesium citrate (picoprep)). Patients were encouraged to drink freely of clear fluids while taking the preparation in line with the manufacturer’s instructions, while obstaining from solid food for 24 hours prior to colonoscopy

Sponsors

Frank Frizelle
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

All patients (male and female, over 16 years , no maximum age limit) coming forward for colonoscopy who were fit for procedure.

Exclusion criteria

Pregnant, suspected or known obstructing lesion.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026